Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Total 13F shares
-
362,944,198
-
Share change
-
-3,317,915
-
Total reported value
-
$29,256,676,812
-
Put/Call ratio
-
120%
-
Price per share
-
$80.54
-
Number of holders
-
740
-
Value change
-
-$228,582,348
-
Number of buys
-
333
-
Number of sells
-
361
Institutional Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2022
As of 30 Sep 2022,
DEXCOM INC - Common Stock (DXCM) was held by
740 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
362,944,198 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Capital Research Global Investors, JPMORGAN CHASE & CO, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, and Nuveen Asset Management, LLC.
This page lists
753
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.